marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2022
added 08-16-2022
Global Cord Blood Corporation Balance Sheet 2011-2024 | CO
Annual Balance Sheet Global Cord Blood Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-6.07 B | -5.47 B | -5 B | -4.25 B | -2.48 B | -2.04 B | -1.56 B | -1.05 B | -692 M | -749 M | -566 M | |
Long Term Debt |
- | 147 K | - | - | - | - | 906 M | 816 M | 778 M | 752 M | - | - |
Long Term Debt Current |
147 K | 1.64 M | 1.72 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 2.53 B | 2.26 B | 1.89 B | 2.51 B | 2.16 B | 1.79 B | 1.41 B | 391 M | 220 M |
Total Current Liabilities |
647 M | 626 M | 571 M | 596 M | 468 M | 1.45 B | 468 M | 420 M | 397 M | 332 M | 197 M | - |
Total Liabilities |
3.65 B | 3.52 B | 3.33 B | 3.13 B | 2.73 B | 3.34 B | 2.97 B | 2.58 B | 2.19 B | 1.74 B | 589 M | 470 M |
Deferred Revenue |
458 M | 449 M | 403 M | 462 M | 366 M | 324 M | 258 M | 220 M | 196 M | 172 M | 106 M | 82.3 M |
Retained Earnings |
2.89 B | 2.39 B | 1.88 B | 1.41 B | 1.12 B | 880 M | 754 M | 663 M | 555 M | 423 M | 311 M | 179 M |
Total Assets |
8.53 B | 7.91 B | 7.22 B | 6.55 B | 5.84 B | 5.18 B | 4.69 B | 4.12 B | 3.63 B | 2.99 B | 1.82 B | 1.56 B |
Cash and Cash Equivalents |
6.66 B | 6.08 B | 5.47 B | 5 B | 4.25 B | 3.51 B | 3.01 B | 2.44 B | 1.88 B | 1.49 B | 794 M | 611 M |
Book Value |
4.88 B | 4.39 B | 3.89 B | 3.42 B | 3.12 B | 1.84 B | 1.71 B | 1.54 B | 1.44 B | 1.24 B | 1.24 B | 1.09 B |
Total Shareholders Equity |
4.88 B | 4.38 B | 3.89 B | 3.42 B | 3.11 B | 1.84 B | 1.71 B | 1.54 B | 1.44 B | 1.24 B | 1.2 B | 1.09 B |
All numbers in CNY currency
Quarterly Balance Sheet Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | 50 K | - | 147 K | - | 1.72 M | - | 1.78 M | - | 3.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 755 M | - | 752 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | 3.65 B | - | 3.6 B | - | 3.52 B | - | 3.42 B | - | 3.33 B | - | 3.27 B | - | 3.13 B | - | 2.92 B | - | 2.73 B | - | 2.58 B | - | 3.34 B | - | 3.1 B | - | 2.97 B | - | 2.75 B | - | 2.57 B | - | 2.37 B | - | 2.19 B | - | 1.9 B | 1.8 B | 1.74 B | - | 1.22 B | 1.06 B | 589 M | 524 M | 485 M | - | 470 M |
Deferred Revenue |
- | - | - | 458 M | - | 451 M | - | 449 M | - | 421 M | - | 403 M | - | 444 M | - | 462 M | - | 388 M | - | 366 M | - | 375 M | - | 324 M | - | 293 M | - | 258 M | - | 248 M | - | 220 M | - | 208 M | - | 196 M | - | 181 M | 176 M | 172 M | - | 151 M | 130 M | 106 M | 91.3 M | 87.2 M | - | 82.3 M |
Retained Earnings |
- | - | - | 2.89 B | - | 2.65 B | - | 2.39 B | - | 2.14 B | - | 1.88 B | - | 1.64 B | - | 1.41 B | - | 1.25 B | - | 1.12 B | - | 1.02 B | - | 880 M | - | 786 M | - | 754 M | - | 695 M | - | 663 M | - | 612 M | - | 555 M | - | 481 M | 456 M | 423 M | - | 367 M | 342 M | 311 M | 282 M | 242 M | - | 179 M |
Total Assets |
- | - | - | 8.53 B | - | 8.26 B | - | 7.91 B | - | 7.57 B | - | 7.22 B | - | 6.95 B | - | 6.55 B | - | 6.2 B | - | 5.84 B | - | 5.57 B | - | 5.18 B | - | 4.85 B | - | 4.69 B | - | 4.37 B | - | 4.11 B | - | 3.87 B | - | 3.63 B | - | 3.29 B | 3.11 B | 2.99 B | - | 2.42 B | 2.27 B | 1.82 B | 1.67 B | 1.6 B | - | 1.56 B |
Cash and Cash Equivalents |
- | - | - | 6.66 B | - | 6.39 B | - | 6.08 B | - | 5.73 B | - | 5.47 B | - | 5.37 B | - | 5 B | - | 4.61 B | - | 4.25 B | - | 3.93 B | - | 3.51 B | - | 3.14 B | - | 3.01 B | - | 2.67 B | - | 2.44 B | - | 2.16 B | - | 1.88 B | - | 1.67 B | 1.56 B | 1.49 B | - | 1.32 B | 1.15 B | 794 M | 717 M | 636 M | - | 611 M |
Book Value |
- | - | - | 4.88 B | - | 4.65 B | - | 4.39 B | - | 4.15 B | - | 3.89 B | - | 3.68 B | - | 3.42 B | - | 3.28 B | - | 3.12 B | - | 2.98 B | - | 1.84 B | - | 1.75 B | - | 1.71 B | - | 1.62 B | - | 1.54 B | - | 1.49 B | - | 1.44 B | - | 1.39 B | 1.31 B | 1.24 B | - | 1.2 B | 1.21 B | 1.24 B | 1.15 B | 1.11 B | - | 1.09 B |
Total Shareholders Equity |
- | - | - | 4.88 B | - | 4.64 B | 4.53 B | 4.38 B | - | 4.14 B | 4.02 B | 3.88 B | - | 3.67 B | 3.54 B | 3.42 B | - | 3.27 B | 3.15 B | 3.11 B | - | 2.97 B | - | 1.84 B | - | 1.75 B | - | 1.71 B | - | 1.61 B | - | 1.54 B | - | 1.49 B | - | 1.44 B | - | 1.39 B | 1.3 B | 1.24 B | - | 1.16 B | 1.18 B | 1.2 B | 1.12 B | 1.08 B | - | 1.07 B |
All numbers in CNY currency